Page last updated: 2024-11-05

troglitazone and Rheumatism

troglitazone has been researched along with Rheumatism in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Impressic acid, 3α,11α-dihydroxylup-20(29)-en-28-oic acid, is a lupane-type triterpenoid isolated from Acanthopanax koreanum, which has been used as a Korean folk medicine for rheumatism, hepatitis, diabetes, and inflammatory disorders."3.77Effects of impressic acid from Acanthopanax koreanum on NF-κB and PPARγ activities. ( Kim, JA; Kim, YH; Song, SB; Yang, SY, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JA1
Yang, SY1
Song, SB1
Kim, YH1

Other Studies

1 other study available for troglitazone and Rheumatism

ArticleYear
Effects of impressic acid from Acanthopanax koreanum on NF-κB and PPARγ activities.
    Archives of pharmacal research, 2011, Volume: 34, Issue:8

    Topics: Bone Marrow Cells; Cell Survival; Chromans; Cytokines; Dendritic Cells; Dose-Response Relationship,

2011